Methods for the generation of multispecific and multivalent antibodies

Patent metadata

Field	Value
Publication number	US-9834615-B2
Application number	US-201113210723-A
Country	US
Kind code	B2
Filing date	Aug 16, 2011
Priority date	Aug 16, 2010
Publication date	Dec 5, 2017
Grant date	Dec 5, 2017

Abstract

The invention provides novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule and methods for producing novel bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule. The antibodies are composed of a single heavy chain and two different light chains, one containing a Kappa constant domain and the other of a Lambda constant domain. The invention provides methods for the isolation of antibodies of different specificities but sharing a common heavy chain. The invention also provides methods for the controlled co-expression of two light chains and a single heavy chain leading to the assembly of monospecific and bispecific antibodies. The invention provides a mean of producing a fully human bispecific and bivalent antibody that is unaltered in sequence and does not involve the use of linkers or other non-human sequences, as well as antibody mixtures of two monospecific antibodies and one bispecific antibody. The invention also provides the means of efficiently purifying the bispecific antibody.

First claim

What is claimed is:

1. An isolated bispecific antibody carrying a different specificity in each of a first combining site and a second combining site and consisting of two copies of a single heavy chain polypeptide and a first light chain and a second light chain, wherein the first and second light chains are different, wherein the first light chain comprises a Kappa constant region and a Kappa variable region, wherein the second light chain comprises a Lambda constant region and a Lambda variable region, and wherein the first combining site specifically binds to a first antigen and the second combining site specifically binds to a second antigen.

2. The isolated bispecific antibody of claim 1 , wherein the constant and variable framework region sequences are human.

Assignees

• Fischer Nicolas
• Magistrelli Giovanni
• Gueneau Franck
• Ravn Ulla
• Elson Greg
• Novimmune Sa

Inventors

• Fischer Nicolas
• Magistrelli Giovanni
• Gueneau Franck
• Ravn Ulla
• Elson Greg

Classifications

• C12N15/1075

  by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title

• C07K16/468 Primary

  Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies · CPC title

• C07K2317/32

  specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor · CPC title

• C07K16/249

  Interferons · CPC title

• C07K16/2866

  against receptors for cytokines, lymphokines, interferons · CPC title